BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29666832)

  • 1. Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer.
    Yao N; Jan YJ; Cheng S; Chen JF; Chung LW; Tseng HR; Posadas EM
    Am J Clin Exp Urol; 2018; 6(2):43-54. PubMed ID: 29666832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
    Chen JF; Ho H; Lichterman J; Lu YT; Zhang Y; Garcia MA; Chen SF; Liang AJ; Hodara E; Zhau HE; Hou S; Ahmed RS; Luthringer DJ; Huang J; Li KC; Chung LW; Ke Z; Tseng HR; Posadas EM
    Cancer; 2015 Sep; 121(18):3240-51. PubMed ID: 25975562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
    Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.
    Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR
    Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
    Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
    Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programming thermoresponsiveness of NanoVelcro substrates enables effective purification of circulating tumor cells in lung cancer patients.
    Ke Z; Lin M; Chen JF; Choi JS; Zhang Y; Fong A; Liang AJ; Chen SF; Li Q; Fang W; Zhang P; Garcia MA; Lee T; Song M; Lin HA; Zhao H; Luo SC; Hou S; Yu HH; Tseng HR
    ACS Nano; 2015 Jan; 9(1):62-70. PubMed ID: 25495128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of circulating tumor cells for prostate cancer.
    Cheng S; Chen JF; Lu YT; Chung LWK; Tseng HR; Posadas EM
    Asian J Urol; 2016 Oct; 3(4):254-259. PubMed ID: 29264193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and clinical significance of circulating tumor cell subpopulations in lung cancer.
    O'Flaherty L; Wikman H; Pantel K
    Transl Lung Cancer Res; 2017 Aug; 6(4):431-443. PubMed ID: 28904887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer.
    Gerdtsson AS; Setayesh SM; Malihi PD; Ruiz C; Carlsson A; Nevarez R; Matsumoto N; Gerdtsson E; Zurita A; Logothetis C; Corn PG; Aparicio AM; Hicks J; Kuhn P
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
    Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
    Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine.
    Yang J; Cheng S; Zhang N; Jin Y; Wang Y
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188660. PubMed ID: 34800546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology and clinical potential of circulating tumor cells.
    Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
    Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving insights in blood-based liquid biopsies for prostate cancer interrogation.
    Bonfil RD; Al-Eyd G
    Oncoscience; 2023; 10():69-80. PubMed ID: 38033786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Invasive Profiling of Advanced Prostate Cancer via Multi-Parametric Liquid Biopsy and Radiomic Analysis.
    Morrison G; Buckley J; Ostrow D; Varghese B; Cen SY; Werbin J; Ericson N; Cunha A; Lu YT; George T; Smith J; Quinn D; Duddalwar V; Triche T; Goldkorn A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
    Shao C; Liao CP; Hu P; Chu CY; Zhang L; Bui MH; Ng CS; Josephson DY; Knudsen B; Tighiouart M; Kim HL; Zhau HE; Chung LW; Wang R; Posadas EM
    PLoS One; 2014; 9(2):e88967. PubMed ID: 24551200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).
    Myung JH; Park SJ; Wang AZ; Hong S
    Adv Drug Deliv Rev; 2018 Feb; 125():36-47. PubMed ID: 29247765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.